BioNTech is a biotechnology company based in Mainz, Germany, known for its work in the development of immunotherapies, particularly mRNA-based therapeutics and vaccines. Founded in 2008, BioNTech gained significant recognition for its role in developing one of the first effective COVID-19 vaccines in partnership with Pfizer. The company’s technology focuses on harnessing the body’s immune system to fight diseases, including cancer and infectious diseases, by using messenger RNA (mRNA) to instruct cells to produce proteins that trigger an immune response. BioNTech is committed to advancing personalized medicine and innovative treatment options through its research and development efforts.
BioNTech's mRNA vaccine success transitions to a new chapter focusing on cancer therapies. The company reported a decline in earnings per share to 1.08 euros but beat market expectations. Revenue…